Eudocia Q Lee

Eudocia Q Lee

UNVERIFIED PROFILE

Are you Eudocia Q Lee?   Register this Author

Register author
Eudocia Q Lee

Eudocia Q Lee

Publications by authors named "Eudocia Q Lee"

Are you Eudocia Q Lee?   Register this Author

64Publications

2129Reads

35Profile Views

Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.

J Am Soc Cytopathol 2020 Jan - Feb;9(1):45-54. Epub 2019 Sep 11.

Department of Pathology, Stanford University, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jasc.2019.09.001DOI Listing
September 2019

Local control after brain-directed radiation in patients with cystic versus solid brain metastases.

J Neurooncol 2019 Apr 4;142(2):355-363. Epub 2019 Feb 4.

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03106-1DOI Listing
April 2019

PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma.

Neurology 2018 10 31;91(14):e1355-e1359. Epub 2018 Aug 31.

From the Laura and Isaac Perlmutter Cancer Center (S.C.K.), Brain Tumor Center, NYU Langone Medical Center, New York; Dana-Farber Cancer Institute (L.P.C., D.H., M.R., L.N., E.Q.L., D.A.R., P.Y.W.), Center for Neuro-Oncology; and Department of Radiology (R.H., P.U.), Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006283DOI Listing
October 2018

Brain Tumors.

Am J Med 2018 08 31;131(8):874-882. Epub 2018 Jan 31.

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Mass; Department of Neurology, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2017.12.039DOI Listing
August 2018

Brain Metastases.

Neurol Clin 2018 08 18;36(3):557-577. Epub 2018 Jun 18.

Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ncl.2018.04.010DOI Listing
August 2018

The Interface Between Neurology and Oncology.

Neurol Clin 2018 08 13;36(3):xiii-xiv. Epub 2018 Jun 13.

Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, D2, Boston, MA 02215, USA; Division of Cancer Neurology, Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ncl.2018.05.001DOI Listing
August 2018

The Evolving Landscape of Brain Metastasis.

Trends Cancer 2018 03 21;4(3):176-196. Epub 2018 Feb 21.

Department of Neuro-Oncology, University Hospital Turin, Via Cherasco 15, 10126 Turin, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24058033183001
Publisher Site
http://dx.doi.org/10.1016/j.trecan.2018.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602095PMC
March 2018

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

Neuro Oncol 2017 Oct;19(11):1511-1521

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts; Department of Biostatistics, Harvard T. H. Chan School of Public Health, and Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Department of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737512PMC
October 2017

Response Assessment in Neuro-Oncology Clinical Trials.

J Clin Oncol 2017 Jul 22;35(21):2439-2449. Epub 2017 Jun 22.

Patrick Y. Wen and Eudocia Q. Lee, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Susan M. Chang, University of California, San Francisco, San Francisco, CA; Michael A. Vogelbaum, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Martin J. Van den Bent, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands; and David R. Macdonald, London Regional Cancer Program, Western University, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.7511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516482PMC
July 2017

Corticosteroids for peritumoral edema: time to overcome our addiction?

Neuro Oncol 2016 09 16;18(9):1191-2. Epub 2016 Aug 16.

Center for Neuro-Oncology, Dana-Farber / Brigham and Women's Cancer Center, Boston, MA (E.Q.L., P.Y.W.); Harvard Medical School, Boston, MA (E.Q.L., P.Y.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999008PMC
September 2016

Updates in the management of brain metastases.

Neuro Oncol 2016 08;18(8):1043-65

St. Luke's Radiation Oncology Associates, St. Luke's Cancer Center, Whiteside Institute for Clinical Research and University of Minnesota Duluth, Duluth, Minnesota (N.D.A.); Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (E.Q.L., P.Y.W.); Harvard Medical School, Boston, Massachusetts (E.Q.L., B.M.A., N.U.L., I.F.D., P.Y.W.); Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland (M.P.M.); Department of Medical Oncology, City of Hope, Duarte, California (K.M.); Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (B.M.A.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (N.U.L.); Department of Medicine, Division of Hematology-Oncology, University of North Carolina, Chapel Hill, North Carolina (C.K.A.); Department of Neurology/Neuro-Oncology, University of Turin, Turin, Italy (R.S.); Division of Medical Oncology, University of Colorado Denver, Denver, Colorado (D.R.C.); Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio (M.A.V.); Department of Neurosurgery, Brigham & Women's Hospital, Boston, Massachusetts (I.F.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933491PMC
August 2016

Assessment of Brain Tumor Response: RANO and Its Offspring.

Curr Treat Options Oncol 2016 07;17(7):35

Department of Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-016-0413-5DOI Listing
July 2016

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Neuro Oncol 2016 06 21;18(6):849-54. Epub 2016 Feb 21.

Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (E.Q.L., D.A.R., A.D.N., L.N., M.L.R., B.M.A., N.D.A., L.D., J.S., D.L., S.F.R., J.P., K.H.S., S.C.G., S.H., P.Y.W.); Harvard Medical School, Boston, Massachusetts (E.Q.L., E.T.W., D.A.R., A.D.N., L.N., M.L.R., B.M.A., N.D.A., P.Y.W.); Massachusetts General Hospital, Boston, Massachusetts (A.M.); University of Pittsburgh, Pittsburgh, Pennsylvania (J.D.); University of California San Diego, La Jolla, California (S.K.); Beth Israel Deaconess Medical Center, Boston, Massachusetts (E.T.W.); Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire (C.E.F.); Geisel School of Medicine at Dartmouth, Hanover, New Hampshire (C.E.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864265PMC
June 2016

Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy.

J Clin Oncol 2016 Apr 4;34(10):e87-9. Epub 2014 Aug 4.

Harvard Medical School; and Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.1766DOI Listing
April 2016

A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.

Neuro Oncol 2016 Feb 30;18(2):269-74. Epub 2015 Aug 30.

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (A.A.A., M.C.H., N.D.A., B.M.A.); Department of Pathology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (M.A., K.L.L., A.H.L., S.S.); Department of Neurosurgery, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (W.L.B., O.A-M., I.F.D.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (E.Q.L., L.N., M.L.R., A.D.N., D.A.R., P.Y.W., R.B.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724184PMC
February 2016

Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.

World Neurosurg 2016 Jan 28;85:96-105. Epub 2015 Jul 28.

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2015.07.032DOI Listing
January 2016

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.

Neuro Oncol 2015 Oct 9;17(10):1344-55. Epub 2015 Mar 9.

Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., S.H., D.K., Y.J.K., K.L.L.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.E.S., L.B., M.B., D.A.R., E.Q.L., M.L.R., A.D.N., L.N., S.R., L.M.D., D.C.L., P.K., B.J.R., P.Y.W., R.B., K.L.L.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (W.L.B., E.B.C, O.A.-M., M.D.J., A.J.G., I.F.D., E.A.C.); Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (L.T.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (M.H., A.A.A., N.D.A., B.M.A.); Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (M.H., A.A.A., N.D.A., B.M.A.); Harvard Radiation Oncology Program, Boston, Massachusetts (A.R.); Kravis Center for Molecular Oncology & Department of Epidemiology and Biostatistics, Memorial Sloan- Kettering Cancer Center, New York, New York (N.S.); Broad Institute, Cambridge, Massachusetts (R.B.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., A.D., J.B.C., M.A., S.S., R.D.F., N.I.L., A.H.L., K.L.L.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578577PMC
October 2015

Computationally simple analysis of matched, outcome-based studies of ordinal disease states.

Stat Med 2015 Jul 22;34(17):2514-27. Epub 2015 Apr 22.

Brain Tumor Center, Massachusetts General Hospital, Boston, MA, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.6503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490001PMC
July 2015

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.

Neuro Oncol 2015 Jun 7;17(6):862-7. Epub 2015 Jan 7.

Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (E.Q.L., D.A.R., A.D.N., L.N., R.B., M.L.R., K.H., C.M., K.H.S., S.C.G., B.W., K.L.L., P.Y.W.); University of Virginia, Charlottesville, Virginia (D.S.); University of Pittsburgh, Pittsburgh, Pennsylvania (J.D.); Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (A.S.C., T,T.B., A.M.); Central DuPage Hospital, Warrenville, Illinois (S.A.G.); Northwestern University, Chicago, Illinois (J.J.R.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/17/6/862.fu
Web Search
http://neuro-oncology.oxfordjournals.org/cgi/doi/10.1093/neu
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483124PMC
June 2015

Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.

Int J Radiat Oncol Biol Phys 2015 Jun 1;92(2):384-9. Epub 2015 Apr 1.

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.01.017DOI Listing
June 2015

Medical management of brain tumors and the sequelae of treatment.

Neuro Oncol 2015 Apr 30;17(4):488-504. Epub 2014 Oct 30.

Neuro-Oncology Center, University of Virginia Medical Center, Charlottesville, Virginia (D.S.); Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts (E.Q.L., L.N., A.D.N., D.A.R., P.Y.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483077PMC
April 2015

Nervous system metastases from systemic cancer.

Authors:
Eudocia Q Lee

Continuum (Minneap Minn) 2015 Apr;21(2 Neuro-oncology):415-28

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.CON.0000464178.81957.18DOI Listing
April 2015

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.

Neurology 2015 Jan 19;84(3):280-6. Epub 2014 Dec 19.

From the Division of Cancer Neurology, Department of Neurology (A.D.N., E.Q.L., P.Y.W.), and Departments of Pathology (K.L.L.) and Medicine (R.B.), Brigham and Women's Hospital, Boston, MA; Center for Neuro-Oncology (A.D.N., S.N.H., D.A.R., R.B., E.Q.L., L.D., D.L., M.G., K.H.S., C.M., P.Y.W.), Dana-Farber/Brigham and Women's Cancer Center; Department of Medicine (R.B.), Harvard Medical School (A.D.N., K.L.L., D.A.R., T.T.B., S.R.P., E.T.W., R.B., E.Q.L., P.Y.W.), Boston; Department of Medical Oncology, Center for Molecular Oncologic Pathology (K.L.L., S.H.), and Departments of Medical Oncology and Cancer Biology (R.B.), Dana-Farber Cancer Institute, Boston; Massachusetts General Hospital Biostatistics Center (A.M.); Brain Tumor Center (T.J.K.), Memorial Sloan-Kettering Cancer Center, New York, NY; Pappas Center for Neuro-Oncology (T.T.B., S.R.P.), Massachusetts General Hospital, Boston; Department of Neurology (J.J.R.), Northwestern University Feinberg School of Medicine, Chicago, IL; Brain Tumor Center (E.T.W.), Beth-Israel Deaconess Medical Center, Boston; Adult Neuro-Oncology Program (J.D.), University of Pittsburgh Medical Center, Pittsburgh, PA; Comprehensive Cancer Center (G.J.L.), Wake Forest University Baptist Medical Center, Winston-Salem, NC; and Departments of Neurosurgery and Neurology (S.P.), Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335993PMC
January 2015

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.

Neuro Oncol 2014 Nov 2;16(11):1547-53. Epub 2014 Jun 2.

Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, Massachusetts (A.A.A.); Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (N.D.A., B.M.A.); Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts (P.C.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (E.B.C., A.J.G., M.D.J., O.A-M., I.F.D.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (P.Y.W., D.A.R., E.Q.L., L.N., M.L.R., R.B.); Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania (S.E.W.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., S.S., M.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201070PMC
November 2014

Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab.

Neuro Oncol 2014 Nov 23;16(11):1523-9. Epub 2014 Jun 23.

Harvard Medical School, Boston, Massachusetts (R.R., A.D.N., D.A.R., L.N., M.L.R., R.B., B.M.A., R.Y.H., P.Y.W., E.Q.L.); Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (K.H., A.D.N., D.A.R., L.N., M.L.R., R.B., L.D., S.R., J.R., D.L., P.Y.W., E.Q.L.); Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts (A.D.N., D.A.R., L.N., M.L.R., R.B., P.Y.W., E.Q.L.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (B.M.A.); Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts (R.Y.H.); Boston University School of Medicine, Boston, Massachusetts (A.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201074PMC
November 2014

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma.

J Neurooncol 2013 Oct 5;115(1):71-7. Epub 2013 Jul 5.

Department of Neuro-Oncology, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1196-1DOI Listing
October 2013

The role of MGMT testing in clinical practice: a report of the association for molecular pathology.

J Mol Diagn 2013 Sep 17;15(5):539-55. Epub 2013 Jul 17.

Department of Pathology, Henry Ford Hospital, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2013.05.011DOI Listing
September 2013

Treatment options in newly diagnosed glioblastoma.

Curr Treat Options Neurol 2013 Jun;15(3):281-8

Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11940-013-0226-9DOI Listing
June 2013

Update on bevacizumab and other angiogenesis inhibitors for brain cancer.

Expert Opin Emerg Drugs 2013 Jun 14;18(2):137-53. Epub 2013 May 14.

Dana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.2013.794784DOI Listing
June 2013

PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.

J Neurooncol 2013 May 12;113(1):143-7. Epub 2013 Mar 12.

Department of Internal Medicine and Markey Cancer Center, University of Kentucky, Lexington, KY, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-013-1100-z
Publisher Site
http://dx.doi.org/10.1007/s11060-013-1100-zDOI Listing
May 2013

Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.

JAMA Ophthalmol 2013 Apr;131(4):514-21

Department of Ophthalmology and Vision Sciences, University of Toronto, St Michael’s Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaophthalmol.2013.2299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625475PMC
April 2013

Current and future directions for Phase II trials in high-grade glioma.

Expert Rev Neurother 2013 Apr;13(4):369-87

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 75 Francis Street, ASB1-L2, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ern.12.158DOI Listing
April 2013

Central nervous system complications of cancer therapy.

J Support Oncol 2012 Jul-Aug;10(4):133-41. Epub 2012 Apr 27.

Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suponc.2011.11.002DOI Listing
September 2012

Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.

J Clin Oncol 2012 Sep 29;30(26):3258-63. Epub 2012 May 29.

Dana-Farber Cancer Institute, Harvard School of Public Health and Dana-Farber/ Brigham and Women's Cancer Center, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2012/05/29/JCO.2011.39
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2011.39.8420
Publisher Site
http://dx.doi.org/10.1200/JCO.2011.39.8420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434985PMC
September 2012

Current clinical development of PI3K pathway inhibitors in glioblastoma.

Neuro Oncol 2012 Jul 22;14(7):819-29. Epub 2012 May 22.

Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nos117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379803PMC
July 2012